A biodiversidade do Brasil é extremamente vasta, masapenas uma pequena fração das suas potencialidades éutilizada para pesquisa e desenvolvimento demedicamentos. As plantas medicinais e seus metabólitossecundários podem representar a oportunidade deelaboração de tratamentos eficazes e de baixo custo. Esteartigo de revisão de literatura busca promover aimportância da biodiversidade vegetal brasileira nodesenvolvimento dos recursos de saúde. Para issorealizou-se busca nas principais bases de dados nacionaise internacionais (Scielo, Lilacs, Medline/Pubmed e GoogleScholar). Apesar de possuir uma riqueza aindainexplorada, grandes áreas do Cerrado, Amazônia eCaatinga já sofreram desmatamento. Considera-senecessário e urgente que mais políticas governamentais deproteção dessas áreas sejam desenvolvidas, a fim deincentivar a conservação da biodiversidade da flora, emespecial de plantas medicinais, e assegurar a variabilidadegenética e as características fitoquímicas que são fontesimportantes na obtenção de identidades molecularesnovas para a indústria farmacêutica.

Gastritis is an inflammation of the mucosa that lines the inner walls of the stomach. This state of high prevalence worldwide and its current treatments still show indecisions regarding trust in long-term treatment. Faced with this problem, subaltern possibilities to drug therapy of gastrointestinal disorders, such as chronic gastritis and other inflammatory pathologies, are significant objects for research. Phytotherapeutic treatment, through medicinal plants, is a practice used by humanity since the beginning of time; in which the treatment of diseases takes place through herbs and/or plants with curative powers, which favor the improvement of the individual's health and well-being, reaching the point of developing a curative process. The article addresses evidence gathered in the literature that seeks to find the effectiveness of Aloe vera L. in the treatment of inflammatory dysfunction related to gastritis and gastrointestinal disorders.

The present study aims to analyze the profile of patients who were hospitalized for decompensation of Primary Arterial Hypertension within the northern health macro-region of Maranhão through an epidemiological study in the SIH/SUS, considering the period 2016-2020. As a methodology, a documental evaluation study was carried out, using public data from the statistical tools of the DATASUS network, which were obtained through access as an individual according to the access rights granted by Law No. 12,527/2011. The study population was made up of the northern health macro-region of Maranhão, which encompasses around 4,084,650 inhabitants and which made use of hospital services. Data were filtered by quantitative and care characteristics, using subfilters of individual characteristics and care character, which encompassed all procedures performed in the health network belonging to the macro-region of northern Maranhão, considering the historical series of the last 5 years for the hospital care (2016-2020). The data found in this study demonstrate that female patients have had a greater tendency to hospitalizations due to Systemic Arterial Hypertension and even despite this trend, the lethality for males is substantially higher, also having a positive correlation of deaths with the increase of age. Thus, this study hopes to contribute to a better understanding of the impacts of Primary Arterial Hypertension on health systems.

Introduction: The cancer patient requires several treatments, so the work aimed at this patient should be performed in a broad erway. The multiprofessional team is made up of doctors, nurses, nutritionists, psychologists, and the pharmacist, who is increasingly conquering his space. Objective: To know and discus sthrough a bibliographic survey the advance softhe pharmacist's performance in oncology. Methodology: This is a literature review through searches on LILACS, SciELO, MEDLINE, Science Direct and VHL platforms, articles and theses published from 2014 to 2019. Results and Discussion: The oncology pharmacist becomes the main instrument to obtain the proper quality of individualized pharmacotherapy. Regarding chemotherapy, the professional acts by selecting, acquiring, storing and standardizing the components that are paramount from the preparation to the dispensation of these antineoplastics. Even with all the support and attributions focused on the pharmaceutical profession, it is known that the totally satisfactory performance with pharmaceutical attention in oncologyis still a challenge. According to a survey of the profile of the pharmacist's performance in oncology conducted by Sobrafo in relation to the total hours dedicated to manipulation, it is true to say that 34.5% of these professionals reach 6 hours of manipulation and 15.6% reach 8 hours in this sector. Conclusion: Even with all the attributions and advances of the pharmaceutical professional, there are still some challenges related to the full exercise of pharmaceutical care, such as the excess of time in the handling sector, which makes other activities difficult.

  Endometriosis is a gynecological disease characterized by the presence of endometrium as tissue-epithelium and stroma that develops outside the uterine cavity. It is a chronic, estrogen-dependent disease, is associated with pelvic pain, dysmenorrhea, dyspareunia and infertility. Given the great impact of this disease on the quality of life of women, there has been a growing interest in the discovery of new drugs that are more effective, tolerability and safety. For this, a literature review was carried out from articles published between 2008 and 2018 available regarding pharmacological treatments for endometriosis in the SCIENCE DIRECT and PUBMED databases. A total of 223 articles published in the last 10 years were found in "Portuguese and English". After evaluating the articles, 15 articles were selected for the present study, which complied with all the eligibility criteria proposed in the methodology. It was concluded that we can count on several types of treatments for endometriosis, but most have the objective of treating the symptoms associated with endometriosis. Currently, the specific treatment we can count on is dienogeste. In addition, there are many studies in search of new drugs and promising treatments for this pathology. Thus, more research is needed regarding the theme and that the pharmacist plays a fundamental role in the adherence to the patient's treatment.

According to research carried out in China, the place of origin of the pandemic, cardiac injuries have become characteristic of this new virus, reaching about 30% of patients and leading to 40% of deaths. Several changes were observed such as: myocardial injury (20% of cases), arrhythmias (16%), myocarditis (10%), in addition to heart failure (HF) and shock (up to 5% of cases). The objective of this work is to inform and describe the increase in cardiovascular diseases caused by the new virus. And show the importance of more studies on the area. Data were collected using the scientific bases: Latin American and Caribbean Literature in Health Sciences (LILACS), National Library of medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library - (BVS), Scientific Eletronic Library Online (SCIELO), Cochrane Library, HighWire Press, Scopus and Elsevier. Approximately 600 articles were found, languages were checked, and if it was really about the correlation of cardiovascular problems and the new virus, then 39 articles were obtained for the discussion. This work concludes that, according to research, there is a great correlation between the virus and cardiovascular diseases and myocardial injuries, due to the increase in troponin, leading patients to major complications. This is also due to the increase in markers leading to cardiovascular injuries.